Australia News
-
Atcor's SphygmoCor XCEL gets Mexican nod
Australia | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system which measures central aor...Read more
-
Avexa to invest in mining to fund drug development
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2012
Singapore: How far will a drug company go to fund drug discovery and development? Melborne-based biotechnology company A...Read more
-
Clinuvel gets positive results in Scenesse trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...Read more
-
BioPharma Asia: Dr Deborah Rathjen wins Life Science Woman Executive of the Year award
Australia | Influencers | By BioSpectrum Bureau | 3 Comment | 17 Mar, 2014
Singapore: Dr Deborah Rathjen, CEO of Australia based Bionomics, was awarded the Life Science Woman Executive of the Yea...Read more
-
Hyaluronic acid properties to enhance drug delivery
Australia | News | By Nandita Singh | 0 Comment | 14 Mar, 2012
A company that has been leveraging on drug delivery products is Alchemia. Its HyACT technology uses hyaluronic acid's (H...Read more
-
Pfizer to shut plant in Australia, slash 140 jobs
Australia | News | By BioSpectrum Bureau | 0 Comment | 27 Sep, 2013
Singapore: Pfizer will make a phased exit of its West Ryde plant in Australia, which produces tablets and capsules for b...Read more
-
BioDiem BDM-1 gets Chinese divisional patent
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Feb, 2013
Singapore: BioDiem received a grant of a Chinese divisional patent, expanding the patent position for its novel antimicr...Read more
-
Lawrence Gozlan is part of AusBiotech board
Australia | News | By BioSpectrum Bureau | 0 Comment | 28 Mar, 2013
Singapore: AusBiotech has appointed Mr Lawrence Gozlan as a non-executive director to its board. He has experience in gl...Read more
-
Vaxxas bags AusBiotech emerging company award
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012
Singapore: Vaxxas, a UniQuest start-up established in 2011 to commercialize the Nanopatch vaccine delivery system based...Read more
-
Bionomics MD Deborah Rathjen is PIC's new chair
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2013
Singapore: Dr Deborah Rathjen, managing director of Bionomics and chair of AusBiotech, has been elected as the chair of ...Read more
-
Phosphagenics to initate Ph 2 trial of pain reducing patch
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2014
Singapore: Australian drug delivery company, Phosphagenics, has received regulatory nod to commence proof of concept of ...Read more
-
Phylogica gets patent to model libraries from protein
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2013
Singapore: Australia-based Phylogica recieved allowance of its US patent application for synthetic Phylomer libraries. T...Read more
-
Mesoblast to develop neuro diseases therapies
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
Singapore: Australian company Mesoblast has outlined the company's strategic plans to develop adult stem cell therapies...Read more
-
Melbourne institute gets $590k funding for stomach cancer
Australia | News | By BioSpectrum Bureau | 0 Comment | 13 Mar, 2013
Singapore: Scientists at the Walter and Eliza Hall Institute in Melbourne, Australia, have been awarded funding from Can...Read more
-
Alchemia records $3.5 mn profit in Q2 2013
Australia | Company results | By BioSpectrum Bureau | 4 Comment | 21 Aug, 2013
Singapore: Australian drug discovery and development company Alchemia reported a record quarterly profit share of $3.5 m...Read more
-
Starpharma drug targets cancer more effectively
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Australia-based Starpharma reported significant tumor-targeting results with its proprietary dendrimer-doceta...Read more
-
TGA nod for iSonea's wheeze detection device
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Medical technology company iSonea received approval from Australia's Therapeutic Goods Administration (TGA) t...Read more
-
ResMed revenue increases 11% to $414 mn
Australia | Company results | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: Australia-based ResMed reported record revenue and income for the quarter ending June 30, 2013. Revenue was $...Read more
